Clinical trial
Activity of Mefloquine Against Urinary Schistosomiasis
NCT01132248 is registered in ClinicalTrials.gov with Albert Schweitzer Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Activity of Mefloquine Against Urinary Schistosomiasis
- Lead sponsor
- Albert Schweitzer Hospital
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- May 31, 2010
- Completion date
- December 31, 2012
- Enrollment
- 65 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
urinary schistosomiasis